Modulation of kynurenic acid synthesis in rodent models of retinal degeneration

Projektinformationen

REJDAK, ROBERT

ID Finanzhilfevereinbarung: QLK2-CT-2002-51562

Projekt abgeschlossen

Startdatum 1 Januar 2003

Enddatum 31 Dezember 2004

Finanziert unter

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Gesamtkosten € 147 150,00

EU-Beitrag € 147 150,00

Koordiniert durch

THE UNIVERSITY OF TUEBINGEN
Germany

Ziel

Gynogenic acid (KYNA) may act as a neuroprotectant against retinal degeneration. I will investigate modulation of its retinal content and the expression and cellular distribution of key enzymes of KYNA synthesis kynurenine ammotransferases I and II (KAT I and II) in rodent models of optic nerve trauma, glaucoma and diabetic retinopathy

Wissenschaftliches Gebiet

• medical and health sciences › clinical medicine › ophthalmology › glaucoma
• medical and health sciences › clinical medicine › ophthalmology › retinopathy
• natural sciences › biological sciences › biochemistry › biomolecules › proteins › enzymes

Programm/Programme

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thema/Themen

• 1.1.1.-2. - Key action Control of Infectious Diseases

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

RGI - Research grants (individual fellowships)

Koordinator

THE UNIVERSITY OF TUEBINGEN

• EU-Beitrag: Keine Daten
• Adresse: Roentgenweg, 11 ; 72076 TUEBINGEN ; Deutschland
• Gesamtkosten: Keine Daten